| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.003 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |